Sabrina Martucci Johnson - 18 Feb 2026 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Reporting relationship: Chef Executive Officer, Director
Issuer ticker: DARE
Reported as of: 18 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Feb 2026, 16:01:50 UTC
Prior SEC filing: 02 Feb 2026
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Sabrina Martucci Johnson

Key filing fact

Sabrina Martucci Johnson filed Form 4 for Dare Bioscience, Inc. (DARE) on 20 Feb 2026.

Key facts

This page summarizes Sabrina Martucci Johnson's Form 4 filing for Dare Bioscience, Inc. (DARE).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Feb 2026, 16:01.

Change

Previous filing in this sequence was filed on 02 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001199102 Primary reporting owner

JOHNSON SABRINA MARTUCCI

Relationship: Chef Executive Officer, Director
Address: 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO
Signature: /s/ Sabrina Martucci Johnson
Signature date: 20 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DARE transaction Derivative

Series A Convertible Preferred Stock

Award

Transaction value
Shares: +10,800
Change %
Price
Shares after: 10,800
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 21,600
Exercise price: $2.50
Footnotes: F1, F2, F3, F4

DARE transaction Derivative

Common Stock Warrant (right to buy)

Award

Transaction value
Shares: +21,600
Change %
Price
Shares after: 21,600
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 21,600
Exercise price: $4.00
Footnotes: F1, F2, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription.

Footnote F2

This security is convertible or exercisable, as applicable, at any time after issuance.

Footnote F3

The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions.

Footnote F4

The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock.

Footnote F5

This security expires on the 36-month anniversary of the date of issuance.